UBS Group
QDEL icon

UBS Group’s QuidelOrtho QDEL Stock Holding History

UBS Group’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,000
Closed -$831K – 9953
2024
Q2 		$831K Buy
+25,000
New +$1.02M ﹤0.01% 4582
2023
Q1 		– Sell
-39,156
Closed -$3.35M – 10224
2022
Q4 		$3.35M Buy
+39,156
New +$3.32M ﹤0.01% 2865
2021
Q3 		– Sell
-200
Closed -$26K – 9974
2021
Q2 		$26K Buy
+200
New +$23.5K ﹤0.01% 7078

Other funds holding QDEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group's QDEL Position: Q2 2026 in Review

UBS Group increased its QuidelOrtho (QDEL) stake by 5.3% in Q2 2026, buying an estimated $382K and bringing the position to 570,926 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #3447.

UBS Group first reported a position in QDEL in Q4 2014 and has held it in 47 quarters since. The position peaked at $15.9M in Q3 2025. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • UBS Group held 570,926 shares of QuidelOrtho worth $10M as of Q2 2026.
  • UBS Group bought 28,924 QuidelOrtho shares in Q2 2026, an estimated $382K.
  • QuidelOrtho made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3447 holding.
  • UBS Group first reported a position in QuidelOrtho in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's QuidelOrtho position peaked at $15.9M in Q3 2025.
  • 245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.